Flagship Pioneering provides $50 mln to Foghorn Therapeutics


Cambridge, Massachusetts-based Foghorn Therapeutics, a developer of therapies for cancer and other serious diseases, has secured $50 million in funding. The investor was Flagship Pioneering.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.